Document is current
Any future updates will be listed below
-
Authors
Werner, Georg https://orcid.org/0000-0001-5328-3049
Damme, Markus
Schludi, Martin
Gnörich, Johannes
Wind, Karin
Fellerer, Katrin
Wefers, Benedikt
Wurst, Wolfgang
Edbauer, Dieter https://orcid.org/0000-0002-7186-4653
Brendel, Matthias
Haass, Christian https://orcid.org/0000-0002-4869-1627
Capell, Anja https://orcid.org/0000-0003-3118-911X
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (HA1737/16-1)
Deutsche Forschungsgemeinschaft (EXC21455SyNetgy‐ID)
Deutsche Forschungsgemeinschaft (390857198)
Helmholtz Association (ZT‐0027)
- License Information
-
More Information
Article History
Received: 17 February 2020
Revised: 5 August 2020
Accepted: 10 August 2020
First Online: 14 September 2020
Conflict of interest
: CH collaborates with Denali Therapeutics, participated on one advisory board meeting of Biogen, and received a speaker honorarium from Novartis and Roche. CH is chief advisor of ISAR Bioscience.
Free to read: This content has been made available to all.
